Postprandial Peaking and Plateauing of Triglycerides and VLDL in Patients with Underlying Cardiovascular Diseases Despite Treatment

CITEDBY Reports

  1. Robert S. Rosenson, Terry A. Jacobson, David Preiss, C. Stephen Djedjos, Ricardo Dent, Ian Bridges, Michael Miller, . Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia. Cardiovascular Drugs and Therapy, 2016; 30(3): 305.
    Crossref
  2. Peter Sabaka, Peter Kruzliak, Ludovit Gaspar, Martin Caprnda, Matej Bendzala, David Balaz, Stanislav Oravec, Andrej Dukat, . Postprandial changes of lipoprotein profile: effect of abdominal obesity. Lipids in Health and Disease, 2013; 12(1): 179.
    Crossref